|Articles|February 1, 2002

February 2002
Volume 8
Issue 2

Evaluation of Agreements Between Managed Care Organizations and Providers of Community-Based Mental Illness and Addiction Disorder Treatments

Author(s)Sara Rosenbaum, JD, D. Richard Mauery, MPH, Joel Teitelbaum, LLM

Download PDF: Evaluation of Agreements Between Managed Care Organizations and Providers of Community-Based Mental Illness and Addiction Disorder Treatments

Articles in this issue

about 24 years ago

Article

"Trial" Prescriptions to Reduce Drug Wastage: Results From Canadian Programs and a Community Demonstration Project

about 24 years ago

Article

Application of Pharmacoeconomics to Formulary Decision Making in Managed Care Organizations

about 24 years ago

Article

Comparison of Two Systems for Clinical Practice Profiling in Diabetic Care: Medical Records Versus Claims and Administrative Data

about 24 years ago

Article

A Comparison of Ambulatory Services for Patients with Managed Care and Fee-for-Service Insurance

about 24 years ago

Article

A New Method for Determining Patient Payments for Outpatient Drugs

about 24 years ago

Article

Expanded Use of Nurse Practitioners

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

Evaluation of Agreements Between Managed Care Organizations and Providers of Community-Based Mental Illness and Addiction Disorder Treatments

Articles in this issue

Newsletter

Related Content

Quality of Life: The Pending Outcome in Idiopathic Pulmonary Fibrosis

Increased Payments to Medicare Advantage Plans for Dually Eligible Beneficiaries

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

Building Trust: Public Priorities for Health Care AI Labeling

Ambient AI Tool Adoption in US Hospitals and Associated Factors

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

How Do GLP-1 Agonists Fit Into Stroke Care?

5 Things to Know About the Oral GLP-1 Era

Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD

Stroke Subtype Does Not Affect Efficacy of Asundexian for Second Stroke Prevention